[1] Li XL, Chen TT, Dong X, et al. Early onset preeclampsia in subsequent pregnancies correlates with early onset preeclampsia in first pregnancy[J]. Eur J Obstet Gynecol Reprod Biol, 2014,177: 94-99. [2] Ghossein-Doha C, Spaanderman M, van Kuijk SMJ, et al. Long-term risk to develop hypertension in women with former preeclampsia a longitudinal pilot study[J]. Reprod Sci, 2014: 1933719113518989. [3] Wikström AK, Stephansson O, Cnattingius S. Previous preeclampsia and risks of adverse outcomes in subsequent nonpreeclamptic pregnancies[J]. Am J Obstet Gynecol, 2011, 204(2): 148. e1-148. e6. [4] He G, Xu W, Chen Y, et al. Abnormal apoptosis of trophoblastic cells is related to the up-regulation of CYP11A gene in placenta of preeclampsia patients[J]. PloS One, 2013, 8(3): e59609. [5] Liang S, Liu X, Fan P, et al. Association between val158Met functional polymorphism in the COMT gene and risk of preeclampsia in a Chinese population[J]. Arch Med Res, 2012, 43(2): 154-158. [6] Albaiges G, Missfelder-Lobos H, Lees C, et al. One-stage screening for pregnancy complications by color Doppler assessment of the uterine arteries at 23 weeks' gestation[J]. Obstet Gynecol, 2000, 96(4): 559-564. [7] Demers S, Bujold E, Arenas E, et al. Prediction of recurrent preeclampsia using first-trimester uterine artery doppler[J]. Am J Perinatol, 2014,31(2):99-104. [8] Sohlberg E, Saghafian-Hedengren S, Bachmayer N, et al. Pre-eclampsia affects cord blood NK cell expression of activation receptors and serum cytokine levels but not CB monocyte characteristics[J]. Am J Reprod Immunol, 2014, 71(2): 178-188. [9] van Rijn BB, Veerbeek JH, Scholtens LC, et al. C-reactive protein and fibrinogen levels as determinants of recurrent preeclampsia: a prospective cohort study[J]. J Hypert, 2014, 32(2): 408-414. [10] Barton JR, Sibai BM. Prediction and prevention of recurrent preeclampsia[J]. Obstet Gynecol, 2008, 112(2, Part 1): 359-372. [11] 申南, 李光辉, 张为远. 小剂量阿司匹林预防妊娠期高血压疾病研究进展[J]. 中国实用妇科与产科杂志, 2013, 29(7): 587-589. [12] Duley L, Henderson-Smart DJ, Meher S, et al. Antiplatelet agents for preventing pre-eclampsia and its complications[J]. Cochrane Database Syst Rev, 2007, 2:CD004659 [13] Poon LCY, Staboulidou I, Maiz N, et al. Hypertensive disorders in pregnancy: screening by uterine artery Doppler at 11~13 weeks[J]. Ultras Obstet Gynecol, 2009, 34(2): 142-148. [14] Souza EV, Torloni MR, Atallah AN, et al. Aspirin plus calcium supplementation to prevent superimposed preeclampsia: a randomized trial[J]. Brazilian J Med Biol Res, 2014, 47(5): 419-425. [15] 陈鹏,刘兴会.妊娠期营养与子痫前期[J]. 中华围产医学杂志, 2014, 17(2):131-134. [16] Hammer A, Bannason J, Lauszus FF. Second trimester rupture in a retroflexed, scarred uterus[J]. J Obstet Gynaecol, 2013, 33(6): 629-629. [17] Rodger MA, Carrier M, Le Gal G, et al. Meta-analysis of low molecular weight heparin to prevent recurrent placenta-mediated pregnancy complications[J]. Blood, 2014,123(6):822-828.. |